• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端磷酸肽降解结构域通过 SCFβ-TrCP 介导的泛素化途径靶向 TAZ/WWTR1 蛋白降解,从而对磷酸肌醇 3-激酶抑制剂产生应答。

The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.

机构信息

Key Laboratory of Molecular Medicine, Ministry of Education, Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Shanghai 200032, China.

出版信息

J Biol Chem. 2012 Jul 27;287(31):26245-53. doi: 10.1074/jbc.M112.382036. Epub 2012 Jun 12.

DOI:10.1074/jbc.M112.382036
PMID:22692215
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3406709/
Abstract

The Hippo tumor suppressor pathway plays a major role in development and organ size control, and its dysregulation contributes to tumorigenesis. TAZ (transcriptional co-activator with PDZ-binding motif; also known as WWTR1) is a transcription co-activator acting downstream of the Hippo pathway, and increased TAZ protein levels have been associated with human cancers, such as breast cancer. Previous studies have shown that TAZ is inhibited by large tumor suppressor (LATS)-dependent phosphorylation, leading to cytoplasmic retention and ubiquitin-dependent degradation. The LATS kinase, a core component of the Hippo pathway, phosphorylates the C-terminal phosphodegron in TAZ to promote its degradation. In this study, we have found that the N-terminal phosphodegron of TAZ also plays a role in TAZ protein level regulation, particularly in response to different status of cellular PI3K signaling. GSK3, which can be inhibited by high PI3K via AKT-dependent inhibitory phosphorylation, phosphorylates the N-terminal phosphodegron in TAZ, and the phosphorylated TAZ binds to β-TrCP subunit of the SCF(β-TrCP) E3 ubiquitin ligase, thereby leading to TAZ ubiquitylation and degradation. We observed that the TAZ protein level is elevated in tumor cells with high PI3K signaling, such as in PTEN mutant cancer cells. This study provides a novel mechanism of TAZ regulation and suggests a role of TAZ in modulating tissue growth and tumor development in response to PI3K signaling.

摘要

Hippo 肿瘤抑制通路在发育和器官大小控制中发挥着重要作用,其失调导致肿瘤发生。TAZ(与 PDZ 结合基序的转录共激活因子;也称为 WWTR1)是 Hippo 通路下游的转录共激活因子,TAZ 蛋白水平的增加与乳腺癌等人类癌症有关。先前的研究表明,TAZ 受 LATS(large tumor suppressor)依赖性磷酸化抑制,导致细胞质滞留和泛素依赖性降解。LATS 激酶是 Hippo 通路的核心组成部分,磷酸化 TAZ 的 C 端磷酸降解基序以促进其降解。在这项研究中,我们发现 TAZ 的 N 端磷酸降解基序也在 TAZ 蛋白水平调节中发挥作用,特别是在细胞 PI3K 信号状态不同时。GSK3 可以通过 AKT 依赖性抑制性磷酸化被高 PI3K 抑制,其磷酸化 TAZ 的 N 端磷酸降解基序,磷酸化的 TAZ 与 SCF(β-TrCP)E3 泛素连接酶的 β-TrCP 亚基结合,从而导致 TAZ 泛素化和降解。我们观察到在具有高 PI3K 信号的肿瘤细胞(如 PTEN 突变的癌细胞)中 TAZ 蛋白水平升高。这项研究提供了 TAZ 调节的新机制,并表明 TAZ 在响应 PI3K 信号调节组织生长和肿瘤发生中发挥作用。

相似文献

1
The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFβ-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition.N 端磷酸肽降解结构域通过 SCFβ-TrCP 介导的泛素化途径靶向 TAZ/WWTR1 蛋白降解,从而对磷酸肌醇 3-激酶抑制剂产生应答。
J Biol Chem. 2012 Jul 27;287(31):26245-53. doi: 10.1074/jbc.M112.382036. Epub 2012 Jun 12.
2
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.河马肿瘤通路通过磷酸化磷酸降解部位并募集 SCF{beta}-TrCP E3 连接酶来促进 TAZ 的降解。
J Biol Chem. 2010 Nov 26;285(48):37159-69. doi: 10.1074/jbc.M110.152942. Epub 2010 Sep 21.
3
The nonreceptor tyrosine kinase c-Src attenuates SCF(β-TrCP) E3-ligase activity abrogating Taz proteasomal degradation.非受体酪氨酸激酶 c-Src 减弱了 SCF(β-TrCP) E3 连接酶的活性,从而阻止了 Taz 的蛋白酶体降解。
Proc Natl Acad Sci U S A. 2017 Feb 14;114(7):1678-1683. doi: 10.1073/pnas.1610223114. Epub 2017 Feb 1.
4
SCF(β-TRCP)-mediated degradation of NEDD4 inhibits tumorigenesis through modulating the PTEN/Akt signaling pathway.SCF(β-TRCP)介导的NEDD4降解通过调节PTEN/Akt信号通路抑制肿瘤发生。
Oncotarget. 2014 Feb 28;5(4):1026-37. doi: 10.18632/oncotarget.1675.
5
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).Lats 和 CK1 的协调磷酸化通过 SCF(beta-TRCP) 调节 YAP 的稳定性。
Genes Dev. 2010 Jan 1;24(1):72-85. doi: 10.1101/gad.1843810.
6
Targeted polyubiquitylation of RASSF1C by the Mule and SCFβ-TrCP ligases in response to DNA damage.DNA 损伤诱导 Mule 和 SCFβ-TrCP 连接酶靶向多泛素化 RASSF1C
Biochem J. 2012 Jan 1;441(1):227-36. doi: 10.1042/BJ20111500.
7
TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells.在哺乳动物细胞中,TAZ蛋白的积累受到YAP丰度的负调控。
J Biol Chem. 2015 Nov 13;290(46):27928-38. doi: 10.1074/jbc.M115.692285. Epub 2015 Oct 2.
8
The SCFβ-TRCP E3 ubiquitin ligase complex targets Lipin1 for ubiquitination and degradation to promote hepatic lipogenesis.SCFβ-TRCP E3泛素连接酶复合物将Lipin1作为泛素化和降解的靶点,以促进肝脏脂肪生成。
Sci Signal. 2017 Jan 3;10(460):eaah4117. doi: 10.1126/scisignal.aah4117.
9
TAZ promotes PC2 degradation through a SCFbeta-Trcp E3 ligase complex.TAZ通过SCFβ - Trcp E3连接酶复合物促进PC2降解。
Mol Cell Biol. 2007 Sep;27(18):6383-95. doi: 10.1128/MCB.00254-07. Epub 2007 Jul 16.
10
GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.GSK3-SCF(FBXW7) 靶向 JunB 进行降解,以在后期开始前保持染色单体的黏合。
Oncogene. 2013 Apr 25;32(17):2189-99. doi: 10.1038/onc.2012.235. Epub 2012 Jun 18.

引用本文的文献

1
Posttranslational modifications of YAP/TAZ: molecular mechanisms and therapeutic opportunities.YAP/TAZ的翻译后修饰:分子机制与治疗机遇
Cell Mol Biol Lett. 2025 Jul 17;30(1):83. doi: 10.1186/s11658-025-00760-4.
2
Identification of YAP regulators through high-throughput screening and NanoBiT-based validation-drug repositioning for cancer therapy.通过高通量筛选和基于纳米生物发光互补技术的验证来鉴定YAP调节剂——用于癌症治疗的药物重新定位
Anim Cells Syst (Seoul). 2025 May 8;29(1):325-338. doi: 10.1080/19768354.2025.2489389. eCollection 2025.
3
The multifaceted roles of the transcriptional coactivator TAZ in extravillous trophoblast development of the human placenta.转录共激活因子TAZ在人胎盘绒毛外滋养层细胞发育中的多方面作用
Proc Natl Acad Sci U S A. 2025 Apr 22;122(16):e2426385122. doi: 10.1073/pnas.2426385122. Epub 2025 Apr 14.
4
Emerging regulatory mechanisms and functions of biomolecular condensates: implications for therapeutic targets.生物分子凝聚物的新兴调控机制与功能:对治疗靶点的启示
Signal Transduct Target Ther. 2025 Jan 6;10(1):4. doi: 10.1038/s41392-024-02070-1.
5
Intra-tumoral YAP and TAZ heterogeneity drives collective NSCLC invasion that is targeted by SUMOylation inhibitor TAK-981.肿瘤内YAP和TAZ的异质性驱动非小细胞肺癌的集体侵袭,而SUMOylation抑制剂TAK-981可靶向这种侵袭。
iScience. 2024 Oct 11;27(11):111133. doi: 10.1016/j.isci.2024.111133. eCollection 2024 Nov 15.
6
Hippo-YAP/TAZ signaling in breast cancer: Reciprocal regulation of microRNAs and implications in precision medicine.乳腺癌中的Hippo-YAP/TAZ信号传导:微小RNA的相互调节及其在精准医学中的意义
Genes Dis. 2023 Mar 23;11(2):760-771. doi: 10.1016/j.gendis.2023.01.017. eCollection 2024 Mar.
7
Endothelial FAT1 inhibits angiogenesis by controlling YAP/TAZ protein degradation via E3 ligase MIB2.内皮细胞 FAT1 通过 E3 连接酶 MIB2 控制 YAP/TAZ 蛋白降解来抑制血管生成。
Nat Commun. 2023 Apr 8;14(1):1980. doi: 10.1038/s41467-023-37671-x.
8
Advances in the potential roles of Cullin-RING ligases in regulating autoimmune diseases.Cullin-RING连接酶在调节自身免疫性疾病中的潜在作用进展
Front Immunol. 2023 Mar 17;14:1125224. doi: 10.3389/fimmu.2023.1125224. eCollection 2023.
9
Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy.非河马激酶:在YAP/TAZ信号传导中的不可或缺作用及在癌症治疗中的意义
Mol Biol Rep. 2023 May;50(5):4565-4578. doi: 10.1007/s11033-023-08329-0. Epub 2023 Mar 6.
10
Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases.Yes 相关蛋白和含 PDZ 结合模体的转录共激活因子在心血管疾病中的作用。
Int J Mol Sci. 2023 Jan 14;24(2):1666. doi: 10.3390/ijms24021666.

本文引用的文献

1
The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.转录共激活因子 TAZ 调节恶性脑胶质瘤中的间充质分化。
Genes Dev. 2011 Dec 15;25(24):2594-609. doi: 10.1101/gad.176800.111.
2
The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells.Hippo 信号转导通路的效应物 TAZ 赋予乳腺癌细胞癌症干细胞相关特性。
Cell. 2011 Nov 11;147(4):759-72. doi: 10.1016/j.cell.2011.09.048.
3
TAZ is a novel oncogene in non-small cell lung cancer.TAZ 是一种非小细胞肺癌中的新型致癌基因。
Oncogene. 2011 May 5;30(18):2181-6. doi: 10.1038/onc.2010.606. Epub 2011 Jan 24.
4
TAZ/WWTR1 is overexpressed in papillary thyroid carcinoma.TAZ/WWTR1 在甲状腺乳头状癌中过表达。
Eur J Cancer. 2011 Apr;47(6):926-33. doi: 10.1016/j.ejca.2010.11.008. Epub 2010 Dec 3.
5
Hippo signaling at a glance.Hippo信号通路简介。
J Cell Sci. 2010 Dec 1;123(Pt 23):4001-6. doi: 10.1242/jcs.069070.
6
WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ.WW 结构域与 Wbp2 的相互作用对于 TAZ 的致癌特性很重要。
Oncogene. 2011 Feb 3;30(5):600-10. doi: 10.1038/onc.2010.438. Epub 2010 Oct 25.
7
The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase.河马肿瘤通路通过磷酸化磷酸降解部位并募集 SCF{beta}-TrCP E3 连接酶来促进 TAZ 的降解。
J Biol Chem. 2010 Nov 26;285(48):37159-69. doi: 10.1074/jbc.M110.152942. Epub 2010 Sep 21.
8
A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP).Lats 和 CK1 的协调磷酸化通过 SCF(beta-TRCP) 调节 YAP 的稳定性。
Genes Dev. 2010 Jan 1;24(1):72-85. doi: 10.1101/gad.1843810.
9
TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition.TEAD转录因子介导TAZ在细胞生长和上皮-间质转化中的功能。
J Biol Chem. 2009 May 15;284(20):13355-13362. doi: 10.1074/jbc.M900843200. Epub 2009 Mar 26.
10
A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.TAZ在乳腺癌细胞迁移、侵袭及肿瘤发生中的作用。
Cancer Res. 2008 Apr 15;68(8):2592-8. doi: 10.1158/0008-5472.CAN-07-2696.